Chromatin/Epigenetics
Chromatin/epigenetics inhibitors are compounds that modulate the structure and function of chromatin or interfere with epigenetic modifications, such as DNA methylation and histone modification. These inhibitors are essential tools for studying gene expression regulation and the role of epigenetics in diseases like cancer, neurological disorders, and developmental abnormalities. By targeting epigenetic processes, these inhibitors can alter gene expression patterns and offer new therapeutic avenues. At CymitQuimica, we provide a wide selection of high-quality chromatin/epigenetics inhibitors to support your research in molecular biology, genetics, and epigenetics.
Subcategories of "Chromatin/Epigenetics"
Products of "Chromatin/Epigenetics"
Sort by
NSD2-PWWP1-IN-1
CAS:NSD2-PWWP1-IN-1 (compound 31) is a potent inhibitor of NSD2-PWWP1 with an IC50 value of 0.64 µM, demonstrating potential applications in cancer research.Formula:C28H30N4Color and Shape:SolidMolecular weight:422.565WWL0245
CAS:WWL0245 is a potent and selective BRD4-targeting PROTAC that exhibits sub-nanomolar degradation efficiency (DC50 < 1 nM) for BRD4 over BRD2/3 and PLK1 (DC50 > 1Formula:C45H51N11O8Purity:98%Color and Shape:SolidMolecular weight:873.963-pyridine toxoflavin
CAS:3-pyridine toxoflavin is a potent KDM4C inhibitor, IC50=19nM.Formula:C12H10N6O2Purity:99.83%Color and Shape:SoildMolecular weight:270.25Ref: TM-T67738
1mg185.00€5mg426.00€10mg627.00€25mg938.00€50mg1,320.00€100mg1,786.00€500mg3,591.00€1mL*10mM (DMSO)378.00€EPZ020411
CAS:EPZ020411 is a specific and effective inhibitor of PRMT6 (IC50=10 nM).Formula:C25H38N4O3Color and Shape:SolidMolecular weight:442.6Tulmimetostat
CAS:Tulmimetostat (CPI-0209) is an orally active EZH1/EZH2 inhibitor.Tulmimetostat has antitumor activity and is used in the study of ovarian cancer and advancedFormula:C28H36ClN3O5SPurity:98.04%Color and Shape:SolidMolecular weight:562.12XAV-939
CAS:XAV-939 (NVP-XAV939) shows the selective inhibition against Wnt/β-catenin-mediated transcription by tankyrase1/2 inhibition (IC50: 11/4 nM in cell-free assay).Formula:C14H11F3N2OSPurity:97.47% - 99.04%Color and Shape:SolidMolecular weight:312.31ZINC13466751
CAS:ZINC13466751 is a potent HIF-1α/von Hippel-Lindau interaction inhibitor(IC50 = 2.0 µM).Formula:C20H21N5O2Purity:99.94%Color and Shape:SolidMolecular weight:363.41Ref: TM-T13398
1mg48.00€5mg97.00€10mg160.00€25mg255.00€50mg353.00€100mg452.00€200mg630.00€1mL*10mM (DMSO)105.00€653-47 hydrochloride
CAS:653-47 hydrochloride boosts CREB inhibition by 666-15 and weakly inhibits CREB itself (IC50: 26.3 μM).Formula:C20H20Cl2N2O3Purity:99.14%Color and Shape:SolidMolecular weight:407.29Ref: TM-T8890
1mg92.00€5mg187.00€10mg354.00€25mg597.00€50mg852.00€100mg1,159.00€500mg2,327.00€1mL*10mM (DMSO)215.00€Olaparib
CAS:View and buy Olaparib from TargetMol.Olaparib is a small molecule inhibitor of PARP1/PARP2.Cited in 10 publications.Formula:C24H23FN4O3Purity:100% - 99.90%Color and Shape:SolidMolecular weight:434.46PROTAC SMARCA2/4-degrader-34
PROTAC SMARCA2/4-degrader-34 (compound 38) serves as an effective degrader of both SMARCA2 and SMARCA4. It demonstrates binding affinity to PXR with a DC50 value of 85.1 nM and reduces the protein expression of 3xFLAG-PXR.Formula:C58H78N8O13SColor and Shape:SolidMolecular weight:1127.35HJ-PI01
CAS:HJ-PI01 (HJ-PI01) is a Pim-2 inhibitor. HJ-PI01 (HJ-PI01) induces apoptosis and autophagic cell death in triple-negative human breast cancer.Formula:C14H11NO2Purity:99.55%Color and Shape:SolidMolecular weight:225.24Ref: TM-T9583
1mg35.00€5mg80.00€10mg116.00€25mg259.00€50mg383.00€100mg545.00€200mg740.00€1mL*10mM (DMSO)77.00€C-82
CAS:C-82 is a specific CBP/β-catenin antagonist. It inhibits the binding between β-catenin and CBP and increases the binding between β-catenin and p300.Formula:C33H34N6O4Purity:98.86% - 99.66%Color and Shape:SolidMolecular weight:578.66JAK1-IN-10
CAS:JAK1-IN-10 (compound 9), a cyano-substituted cyclic hydrazine derivative, functions as a potent and selective inhibitor of JAK1 [1].Formula:C15H17N7Purity:98%Color and Shape:SolidMolecular weight:295.34Tankyrase-IN-5
CAS:Tankyrase-IN-5 (Compound 30f), structurally related to MSC2504877, effectively inhibits tankyrase isoforms TNKS1 and TNKS2, with half-maximal inhibitoryFormula:C17H18N2O2Purity:98%Color and Shape:SolidMolecular weight:282.34AZD5305
CAS:AZD5305 is a potent, selective and oral active PARP inhibitor.Formula:C22H26N6O2Purity:98.68% - 99.19%Color and Shape:SolidMolecular weight:406.48Ref: TM-T9165
1mg113.00€5mg235.00€10mg378.00€25mg630.00€50mg898.00€100mg1,216.00€1mL*10mM (DMSO)259.00€Hinokitiol
CAS:Hinokitiol prevents UVB-caused cell death, boosts antioxidant activity, and hinders breast cancer growth.Formula:C10H12O2Purity:99.49% - 99.67%Color and Shape:SolidMolecular weight:164.2ICG001
CAS:ICG001 antagonizes Wnt signaling, binds CBP with 3 μM IC50, not p300.Formula:C33H32N4O4Purity:99.06% - 99.95%Color and Shape:SolidMolecular weight:548.63Ref: TM-T2237
1mg35.00€5mg70.00€10mg106.00€25mg207.00€50mg360.00€100mg558.00€500mg1,198.00€1mL*10mM (DMSO)86.00€EPZ011989
CAS:EPZ011989: potent, selective oral EZH2 inhibitor, Ki < 3 nM, 15x more selective than EZH1, >3000x over other HMTases.Formula:C35H51N5O4Purity:98% - 99.81%Color and Shape:SolidMolecular weight:605.81GSK8814
CAS:GSK8814 is a selective and ATAD2/2B bromodomain chemical probe and inhibitor (binding constant pKd=8.1 and a pKi=8.9 in BROMOscan).Formula:C28H35F2N5O3Purity:98%Color and Shape:SolidMolecular weight:527.61BRD9 Degrader-1
BRD9 Degrader-1 functions as a BRD9 degrader, demonstrating micromolar binding affinity towards BRD9 and nanomolar affinity for the ternary complex involvingPurity:98%Color and Shape:Odour SolidMM-102
CAS:MM-102 (HMTase Inhibitor IX) is a potent inhibitor of WDR5/MLL interaction with IC50 of 2.4 nM and Ki of less than 1 nM in a WDR5 binding assay.Cost-effective and quality-assured.Formula:C35H49F2N7O4Purity:98.77% - 99.08%Color and Shape:SolidMolecular weight:669.8Ref: TM-T6333
1mg39.00€2mg51.00€5mg105.00€10mg168.00€25mg351.00€50mg543.00€100mg777.00€1mL*10mM (DMSO)156.00€PHD-1-IN-1
CAS:PHD-1-IN-1 is a potent inhibitor of hypoxia-inducible factor prolylhydroxylase domain-1 (PHD-1) enzyme(IC50 = 0.034 μM).Formula:C13H8N4Purity:99.78%Color and Shape:SolidMolecular weight:220.23Aurora A inhibitor 3
Aurora A Inhibitor 3 (Compound 5h) effectively inhibits Aurora-A kinase, exhibiting an IC50 of 0.78 μM, and demonstrates cytotoxicity against MCF-7 and MDA-MB-Purity:98%Color and Shape:Odour SolidKW-2449
CAS:KW-2449 is a multiple-targeted inhibitor, mostly for Flt3, modestly effective to Bcr-Abl, FGFR1, and Aurora A; little inhibitory on PDGFRβ, IGF-1R, EGFR.Formula:C20H20N4OPurity:98.43% - 99.89%Color and Shape:SolidMolecular weight:332.4Tranylcypromine (2-PCPA) hydrochloride
CAS:Tranylcypromine (2-PCPA) HCl, a MAO inhibitor, treats major, dysthymic, and atypical depression.Formula:C9H11N·HClPurity:99.48% - 99.86%Color and Shape:SolidMolecular weight:169.66B2
CAS:B2 (Linazolamide intermediate B impurity 2) promotes inclusion formation in cellular models of Huntington's disease and Parkinson's diseaseFormula:C20H17ClN4O3Purity:99.14%Color and Shape:SolidMolecular weight:396.83LIN28 inhibitor LI71
CAS:LIN28 inhibitor LI71 is a potent and cell-permeable LIN28 inhibitor, which abolishes LIN28-mediated oligouridylation with an IC50 of 7 uM.Formula:C21H21NO3Purity:95.88%Color and Shape:SolidMolecular weight:335.4Ref: TM-T11850
1mg137.00€5mg329.00€10mg494.00€25mg822.00€50mg1,121.00€100mg1,539.00€1mL*10mM (DMSO)360.00€PARP-1-IN-2
CAS:PARP-1-IN-2 is a potent PARP1 inhibitor that crosses the blood-brain barrier (IC50: 149 nM).PARP-1-IN-2 showed significant antiproliferative activity againstFormula:C22H15Cl2N3O2Purity:98.82%Color and Shape:SolidMolecular weight:424.28Ref: TM-T62281
1mg65.00€5mg145.00€10mg226.00€25mg379.00€50mg538.00€100mg730.00€200mg938.00€1mL*10mM (DMSO)155.00€NHWD-870
CAS:NHWD-870 selectively inhibits BET bromodomains BRD2-4, BRDT; potent anti-cancer effect by inducing apoptosis, halting cell growth.Formula:C29H29N7OPurity:98%Color and Shape:SolidMolecular weight:491.59MG 149
CAS:MG 149 (Tip60 HAT inhibitor) is a selective and potent Tip60 inhibitor with IC50 of 74 uM, similar potentcy for MOF(IC50= 47 uM).Formula:C22H28O3Purity:98.28% - 99.1%Color and Shape:SolidMolecular weight:340.46Ref: TM-T6584
1mg52.00€2mg74.00€5mg96.00€10mg170.00€25mg324.00€50mg518.00€100mg747.00€1mL*10mM (DMSO)114.00€AZD5153 6-Hydroxy-2-naphthoic acid
CAS:AZD5153 6-Hydroxy-2-naphthoic acid (AZD5153) is a potent triazolopyridazine-based Bromodomain (BRD4) and Extraterminal (BET) inhibitor used in cancer treatmentsFormula:C25H33N7O3·C11H8O3Purity:100% - ≥95%Color and Shape:SolidMolecular weight:667.75MM-589 TFA
CAS:MM-589 TFA is a potent WD repeat domain 5 (WDR5)inhibitor and mixed lineage leukemia (MLL) protein-protein interaction.Formula:C30H45F3N8O7Purity:98%Color and Shape:SolidMolecular weight:686.72MIV-6R
CAS:MIV-6R inhibits Menin-MLL interaction (IC50: 56 nM) and can be used to study leukemia.Formula:C27H35N3OPurity:100.00% - 99.88%Color and Shape:SolidMolecular weight:417.59Atractylenolide I
CAS:Atractylenolide-I reduces inflammation, improves sepsis, liver, and kidney function, and enhances EOC cell sensitivity to paclitaxel.Formula:C15H18O2Purity:97.55% - 99.83%Color and Shape:SolidMolecular weight:230.3SNS-314 Mesylate
CAS:SNS-314 Mesylate (SNS-314) is an effective and specific Aurora A/B/C inhibitor. SNS-314 is less inhibition of Trk A/B, Fms, Flt4, c-Raf, Axl, and DDR2.Formula:C18H15ClN6OS2·CH4O3SPurity:99.44% - 99.92%Color and Shape:SolidMolecular weight:527.04BMS-P5
CAS:BMS-P5 is a specific and orally active Peptidylarginine Deiminase 4 (PAD4) inhibitor.Formula:C27H33ClN6O2Purity:99.61%Color and Shape:SolidMolecular weight:509.04Ref: TM-T22277
2mg47.00€5mg90.00€10mg143.00€25mg283.00€50mg505.00€100mg802.00€200mg1,074.00€1mL*10mM (DMSO)92.00€CCT 137690
CAS:CCT 137690 is a highly specific and oral-available aurora kinase inhibitor, for aurora A(IC50=15 nM ), B(IC50=25 nM) and C(IC50=19 nM).Formula:C26H31BrN8OPurity:98.51% - 99.82%Color and Shape:SolidMolecular weight:551.48CEP-9722
CAS:CEP-9722 is a PARP-1 and PARP-2 inhibitor with anticancer activity and is used in the study of ovarian cancer.Formula:C24H26N4O3Purity:99.40% - 99.64%Color and Shape:SolidMolecular weight:418.49GSK J5
CAS:GSK J5: schistosome, helminth inhibitor; trematode insecticide; boosts schistosome death dose/time-wise.Formula:C24H27N5O2Purity:100%Color and Shape:SolidMolecular weight:417.5TAK-418
CAS:TAK-418 is an orally active LSD1/KDM1A inhibitor with a 2.9 nM IC50, potential for autism therapy.Formula:C17H25ClN2O2SPurity:98.87%Color and Shape:SolidMolecular weight:356.91Ref: TM-T39252
1mg138.00€5mg329.00€10mg520.00€25mg1,064.00€50mg1,434.00€100mg1,920.00€200mg2,593.00€1mL*10mM (DMSO)386.00€PRMT5-IN-29
CAS:PRMT5-IN-29 is a potent, orally active inhibitor of PRMT5, exhibiting an IC50 value of 1.5 μM, showing promise for use in advanced cancer research [1].Formula:C18H20Cl3N5O5Purity:98%Color and Shape:SolidMolecular weight:492.74Palmatine
CAS:Palmatine, also known as Burasaine, inhibits dopamine production and may treat flavivirus, jaundice, dysentery, hypertension, and liver issues.Formula:C21H22NO4Purity:96.28% - 99.49%Color and Shape:SolidMolecular weight:352.4HIF-2α-IN-4
CAS:HIF-2a translation inhibitor is a compound used as a molecular building block.Formula:C9H9N3O4S2Purity:≥98%Color and Shape:SolidMolecular weight:287.32T-448
CAS:T-448 is a lysine-specific demethylase 1 inhibitor (IC50: 22 nM) that improves learning function in mice.T-448 can be used to study memory deficits.Formula:C19H22N4O3SPurity:97% - 98.63%Color and Shape:SolidMolecular weight:386.47SNDX-5613
CAS:Revumenib (SNDX-5613) is a potent and selective oral inhibitor of menin-KMT2A interaction.Cost-effective and quality-assured.Formula:C32H47FN6O4SPurity:99.12% - 99.12%Color and Shape:SolidMolecular weight:630.82Ref: TM-T12943
1mg73.00€2mg97.00€5mg160.00€10mg274.00€25mg542.00€50mg778.00€100mg1,074.00€1mL*10mM (DMSO)217.00€S2101
CAS:S 2101 is an inhibitor of lysine-specific demethylase 1 (LSD1)(IC50 of 0.99 μM, Ki of 0.61 μM and Kinact/Ki of 4560 M/s).Formula:C16H16ClF2NOPurity:98%Color and Shape:SolidMolecular weight:311.75PFI-3
CAS:PFI-3 is a selective chemical inhibitor for SMARCA (2/4) (Kd = 89 nM)and PBI (5) bromodomains which may result in the delay and prevention of breast cancer.Formula:C19H19N3O2Purity:99.71% - 99.94%Color and Shape:SolidMolecular weight:321.37Ref: TM-T6939
1mg38.00€2mg49.00€5mg78.00€10mg103.00€25mg210.00€50mg319.00€100mg474.00€1mL*10mM (DMSO)78.00€HDAC3-IN-T247
CAS:HDAC3-IN-T247 (HDAC3 inhibitor T247) is a histone deacetylase 3 (HDAC3) inhibitor with antiviral activity that inhibits the proliferation of cancer cells.Formula:C21H19N5OSPurity:98.11% - 98.94%Color and Shape:SolidMolecular weight:389.47Ref: TM-T24131
1mg92.00€5mg188.00€10mg311.00€25mg643.00€50mg914.00€100mg1,216.00€1mL*10mM (DMSO)215.00€Ifidancitinib
CAS:Ifidancitinib (ATI-50002) is a JAK kinase 1/3 inhibitor used to study autoimmune diseases.Formula:C20H18FN5O3Purity:98.05%Color and Shape:SolidMolecular weight:395.39O6BTG-C8-αGlu
CAS:O6BTG-C8-αGlu is an O6-methylguanine-DNA methyltransferase (MGMT) inhibitor with an IC50 of 0.45 μM. At a concentration of 0.1 μM, it fully inhibits MGMT in HeLaS3 cells and demonstrates no cytotoxicity even at prolonged high doses (up to 20 μM). This compound is suitable for research on MGMT-related cancers.Formula:C24H34BrN5O7SColor and Shape:SolidMolecular weight:616.525GNE-049
CAS:GNE-049 is a highly potent and selective inhibitor of CBP (IC50: 1.1 nM in TR-FRET assay).Formula:C27H32F2N6O2Color and Shape:SolidMolecular weight:510.58PBRM1-BD2-IN-2
CAS:PBRM1-BD2-IN-2 selectively inhibits PBRM1 with Kd 9.3μM & IC50 1.0μM, useful in cancer research.Formula:C14H9Cl2FN2OPurity:100%Color and Shape:SoildMolecular weight:311.14Ref: TM-T60156
1mg115.00€5mg255.00€10mg375.00€25mg562.00€50mg787.00€100mg1,074.00€500mg2,157.00€1mL*10mM (DMSO)245.00€JAK-IN-10
CAS:JAK-IN-10 is a JAK inhibitor. JAK-IN-10 can be used for the research of dry eye disorders.Formula:C20H18FN5O3SPurity:98.88%Color and Shape:SolidMolecular weight:427.45Ref: TM-T13571
1mg87.00€5mg177.00€10mg260.00€25mg429.00€50mg605.00€100mg815.00€500mg1,624.00€1mL*10mM (DMSO)188.00€WDR5-IN-6
CAS:WDR5-IN-6 is a WDR5 inhibitor targeting the WBM locus.WDR5-IN-6 is highly synergistic with OICR-9429, a WDR5 inhibitor that targets the WIN locus.WDR5-IN-6Formula:C13H8Cl2N2O2SPurity:99.69%Color and Shape:SoildMolecular weight:327.19PRMT3-IN-4
PRMT3-IN-4 (intermediate 15) is an inhibitor of Protein arginine methyltransferase 3 (PRMT3) and serves as the active control for SGC707. It can be utilized in the synthesis of PROTACs targeting PRMT3 and is applicable in research related to leukemia.Color and Shape:Odour SolidJAK kinase-IN-1
CAS:JAK kinase-IN-1 (Example 1) functions as a potent inhibitor targeting the JAK family, which includes TYK2, JAK1, JAK2, and JAK3, with IC50 values of 4.2 nM, 32Formula:C17H19F2N7OSPurity:98%Color and Shape:SolidMolecular weight:407.441-benzyl-2-ethyl-4,5,6,7-tetrahydro-1H-indol-4-one
CAS:1-benzyl-2-ethyl-4,5,6,7-tetrahydro-1H-indol-4-one is an inhibitor Bromodomain-containing protein 4 (human).Formula:C17H19NOPurity:99.08%Color and Shape:SolidMolecular weight:253.34Ref: TM-T8601
1mg88.00€5mg170.00€10mg259.00€25mg425.00€50mg598.00€100mg810.00€200mg1,074.00€1mL*10mM (DMSO)164.00€ITK inhibitor 2
CAS:ITK inhibitor 2 is a interleukin-2-inducible T-cell kinase (ITK) inhibitor , with an IC50 of 2 nM.Formula:C25H33N5O2Color and Shape:SolidMolecular weight:435.56UNC 669
CAS:UNC 669 is an effective and specific MBT (malignant brain tumor) inhibitor with IC50 of 4.2/3.1 uM for L3MBTL1/3.Formula:C15H20BrN3OPurity:97.38%Color and Shape:SolidMolecular weight:338.24Nicotinamide riboside
CAS:Nicotinamide riboside increases NAD[+] levels and activates SIRT1 and SIRT3, culminating in enhanced oxidative metabolism and protection against high fat diet-Formula:C11H15N2O5Purity:98.61% - 99.58%Color and Shape:SolidMolecular weight:255.25G-631
CAS:G-631 acts as a selective tankyrase inhibitor, effectively hindering tankyrase auto-PARsylation (poly ADP ribosylation) at an IC 50 of 7 nM and suppressing the Wnt signaling pathway. This compound also demonstrates favorable pharmacokinetic properties in mice.Formula:C19H22F2N6O3Color and Shape:SolidMolecular weight:420.41PROTAC HDAC6 degrader 2
PROTAC HDAC6 degrader 2 (Compound 1) is an HDAC6 PROTAC degrader with an IC50 value of 0.643 μM. It facilitates the ubiquitination and degradation of HDAC6 and is applicable in research on hematological and solid cancers.Formula:C34H33F2N9O8Molecular weight:733.678PJ34 hydrochloride
CAS:PJ34 hydrochloride (PJ34 HCl) is a potent specific inhibitor of PARPl/2.Formula:C17H18ClN3O2Purity:98.87% - ≥95%Color and Shape:SolidMolecular weight:331.8Rucaparib
CAS:Rucaparib (PF-01367338) is a orally PARP inhibitor and a H6PD inhibitor. Rucaparib exhibits antitumor activity against CRPC. Cost-effective and quality-assured.Formula:C19H18FN3OPurity:98.37% - 99.80%Color and Shape:SolidMolecular weight:323.36Ref: TM-T4463
2mg48.00€5mg73.00€10mg115.00€25mg173.00€50mg235.00€100mg364.00€200mg540.00€500mg869.00€1mL*10mM (DMSO)81.00€W4275
CAS:W4275 (Compound 42) is a selective NSD2 inhibitor with oral activity and an IC50 of 17 nM. It exhibits antiproliferative activity, with an IC50 of 230 nM against RS411 cells, and significantly inhibits tumor growth in an RS411 tumor xenograft model. Pharmacokinetic analysis in mice shows that W4275 has a favorable oral bioavailability (F is 27.34%). W4275 holds potential for use in cancer research.Formula:C25H36N6O3Color and Shape:SolidMolecular weight:468.59YD23
CAS:YD23 is a PROTAC that induces SMARCA2 degradation, has anticancer activity, and selectively inhibits the growth of SMARCA4 mutant lung cancer cells in vitro.Formula:C38H39FN8O7Purity:99.11%Color and Shape:SolidMolecular weight:738.76Curcumin
CAS:Curcumin (Natural Yellow 3) is a phenolic natural product, an inhibitor of histone acetyltransferase p300/CREB (IC50=25 μM) with specificity.Formula:C21H20O6Purity:95% - 98.98%Color and Shape:Orange-Yellow Crystal Powder; Gives Brownish-Red Color With Alkali; Light-Yellow Color With Acids Physical Description Orange-Yellow Needles (Ntp 1992)Molecular weight:368.3799OF-1
CAS:OF-1 is a potent inhibitor of BRPF1B and BRPF2 bromodomain.Formula:C17H18BrN3O4SPurity:98.55% - ≥95%Color and Shape:SolidMolecular weight:440.31Ref: TM-T2127
1mg38.00€5mg79.00€10mg130.00€25mg254.00€50mg406.00€100mg628.00€200mg879.00€1mL*10mM (DMSO)79.00€LLY-507
CAS:LLY-507 is an effective, cell-active, and specific inhibitor of protein-lysine Methyltransferase SMYD2.Formula:C36H42N6OPurity:99.56% - 99.93%Color and Shape:SolidMolecular weight:574.76Ref: TM-T6879
1mg44.00€2mg55.00€5mg85.00€10mg138.00€25mg304.00€50mg552.00€100mg787.00€1mL*10mM (DMSO)110.00€Nudifloramide
CAS:Nudifloramide (1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxamide) is one of the end degradation products of nicotinamide-adenine dinucleotide (NAD).Formula:C7H8N2O2Purity:99.49% - ≥95%Color and Shape:SolidMolecular weight:152.15Eleven-Nineteen-Leukemia Protein IN-1
CAS:ENL-IN-1: Potent ENL YEATS domain inhibitor with 14.5 nM IC50, enhances thermal stability in vitro.Formula:C27H33N7O2Purity:98%Color and Shape:SolidMolecular weight:487.6Ilginatinib hydrochloride
CAS:Ilginatinib hydrochloride (NS-018 hydrochloride) is a highly active and orally bioavailable inhibitor of JAK2.Formula:C21H21ClFN7Purity:99.55%Color and Shape:SolidMolecular weight:425.89Ref: TM-T12266L2
1mg77.00€5mg165.00€10mg240.00€25mg408.00€50mg562.00€100mg800.00€200mg1,074.00€1mL*10mM (DMSO)177.00€TM11
TM11, a tanshinone analog, serves as an effective inhibitor of HuR, preventing the formation of HuR-RNA complexes. It also reduces LPS-induced inflammatory responses in murine macrophages.Formula:C19H12O5SColor and Shape:SolidMolecular weight:352.36SMD-3040
SMD-3040 is a potent and selective SMARCA2 PROTAC degrader (DC50: 12 nM), which consists of an SMARCA2/4 ligand, a linker, and a VHL ligand.Formula:C52H66N10O5SPurity:98%Color and Shape:SolidMolecular weight:943.21EML741
CAS:EML741 also inhibits DNMT1 (IC50, 3.1 μM), with no effect on DNMT3a or DNMT3b.Formula:C31H49N5O2Purity:98%Color and Shape:SolidMolecular weight:523.75BI-9321 trihydrochloride
CAS:BI-9321 trihydrochloride (BI9321 trihydrochloride) is an NSD3-PWWP1 antagonist that downregulates Myc messenger RNA expression.Formula:C22H24Cl3FN4Purity:99.12% - 99.96%Color and Shape:SolidMolecular weight:469.81JAK-IN-31
CAS:JAK-IN-31 (Example 75), a JAK inhibitor, demonstrates IC50 values of ≤0.01 µM for JAK1, ≤0.01 µM for JAK2, 0.01-0.1 µM for JAK3, and ≤0.01 µM for Tyk2,Formula:C21H19N7O2S2Purity:98%Color and Shape:SolidMolecular weight:465.55HIF-1α-IN-2 hydrochloride
HIF-1α-IN-2 hydrochloride is a potent HIF-1α inhibitor exhibiting anticancer activity, demonstrated by IC50 values of 28 nM in MDA-MB-231 cells and 15 nM inFormula:C21H20ClN3OSPurity:98%Color and Shape:SolidMolecular weight:397.92G5-7
CAS:G5-7 is an oral JAK2 inhibitor targeting EGFR/STAT3 phosphorylation with potential for glioma research.Formula:C22H19F2NO3Purity:97.30%Color and Shape:SolidMolecular weight:383.39Ref: TM-T8742
1mg50.00€5mg97.00€10mg145.00€25mg259.00€50mg374.00€100mg523.00€200mg710.00€1mL*10mM (DMSO)105.00€Niraparib tosylate
CAS:Niraparib tosylate (MK-4827 (tosylate))(with IC50 of 3.8 nM/2.1 nM) is a selective PARP1/PARP2 inhibitor.Formula:C19H20N4O·C7H8O3SPurity:99.34% - 99.87%Color and Shape:SolidMolecular weight:492.59Ref: TM-T6892
2mg46.00€5mg66.00€10mg93.00€25mg117.00€50mg147.00€100mg230.00€500mg563.00€1mL*10mM (DMSO)72.00€VTP50469
CAS:VTP50469 is a highly selective and orally active small molecule inhibitor of the Menin-MLL protein-protein interaction.Cost-effective and quality-assured.Formula:C32H47FN6O4SPurity:98.31% - 98.92%Color and Shape:SolidMolecular weight:630.82Ref: TM-T13336
1mg167.00€5mg354.00€10mg424.00€25mg592.00€50mg755.00€100mg1,017.00€1mL*10mM (DMSO)492.00€EML734
CAS:EML734 is a potent, selective inhibitor of PRMT7 and PRMT9, demonstrating inhibitory concentration 50 (IC50) values of 315 nM for PRMT7 and 0.89 μM for PRMT9.Formula:C27H32N10O7Purity:98%Color and Shape:SolidMolecular weight:608.61AMPK activator 16
CAS:AMPK activator16 (compound 6) functions as an AMP-activated protein kinase (AMPK) inhibitor. It interacts effectively with crucial AMPK residues, significantly activating the enzyme. In N2a cells, AMPK activator16 enhances the expression of phosphorylated AMPK (p-AMPK) and its downstream signaling proteins, such as phosphorylated ACC (Acetyl-CoA Carboxylase) and phosphorylated raptor (p-raptor).Formula:C23H20ClNO5SColor and Shape:SolidMolecular weight:457.927GSK 690 Hydrochloride
CAS:GSK 690 (Hydrochloride) is a reversible lysine specific demethylase 1 (LSD1) inhibitor with a Kd value of 9 nM and IC 50 of 37 nM.Formula:C24H24ClN3OPurity:98%Color and Shape:SolidMolecular weight:405.92RO495
CAS:RO495 (CS-2667), a potent inhibitor of TYK2, inhibits TYK2 with IC50 of 1.5nM as tested in cell-based pharmacological assaysFormula:C17H14Cl2N6OPurity:97.94%Color and Shape:SolidMolecular weight:389.24Ref: TM-T22416
1mg64.00€2mg87.00€5mg117.00€10mg183.00€25mg354.00€50mg520.00€100mg702.00€200mg944.00€1mL*10mM (DMSO)140.00€E3330
CAS:E3330 is a potent and selective APE1(Ref-1) inhibitor, which suppressed NF-kappa B DNA-binding activity.Formula:C21H30O6Purity:98.83%Color and Shape:SolidMolecular weight:378.46Ref: TM-T6823
1mg50.00€2mg72.00€5mg107.00€10mg167.00€25mg304.00€50mg500.00€100mg725.00€200mg1,017.00€500mg1,510.00€1mL*10mM (DMSO)88.00€Ivangustin
CAS:Ivangustin is derived from Inula britannica and exhibits significant cytotoxicity against human cancer cell lines.Formula:C15H20O3Purity:99.86%Color and Shape:SolidMolecular weight:248.32Ref: TM-TN4340
1mg183.00€5mg457.00€10mg652.00€25mg1,026.00€50mg1,406.00€100mg1,890.00€1mL*10mM (DMSO)465.00€MOZ-IN-3
MOZ-IN-3 (Compound 6j), a potent KAT6A (MOZ) acetyltransferase inhibitor with an IC50 of 30 nM, exhibits antitumor activity against multiple myeloid leukemiaFormula:C17H13FN2O3SPurity:98%Color and Shape:SolidMolecular weight:344.36Menin-MLL inhibitor 34
Menin-MLL inhibitor 34 (Compound 37) is a selective and potent inhibitor of Menin-MLL, exhibiting an IC50 of 18.21 nM against Menin. This compound effectively reduces Menin protein levels and downregulates MEN1 transcription, demonstrating sustained anti-leukemia effects.Formula:C40H54FN9O4SColor and Shape:SolidMolecular weight:775.98MicroRNA-21-IN-2
CAS:MicroRNA-21-IN-2 is a potential miR-21 inhibitor with an AC50 value of 3.29 μM. MicroRNA-21-IN-2 can be used to study cancer.Formula:C17H15N3O3SPurity:99.2%Color and Shape:SolidMolecular weight:341.38DCLX069
CAS:DCLX069: PRMT1 inhibitor, IC50=17.9µM, targets SAM pocket, inhibits breast/liver cancer, and AML cell growth.Formula:C20H25N3O2Purity:97.76%Color and Shape:SolidMolecular weight:339.43Ref: TM-T27133
1mg38.00€2mg49.00€5mg79.00€10mg111.00€25mg187.00€50mg305.00€100mg487.00€500mg1,035.00€1mL*10mM (DMSO)92.00€KDM5A-IN-1
CAS:KDM5A-IN-1 is a pan-histidine lysine demethylase 5 KDM5 inhibitor that inhibits KDM5A, KDM5B, and KDM5C.Can be used in the study of cancer.Formula:C15H22N4O2Purity:99.8%Color and Shape:SolidMolecular weight:290.36JAK-IN-5 hydrochloride
CAS:JAK-IN-5 hydrochloride is a JAK inhibitor [1].Formula:C27H32ClFN6OColor and Shape:SolidMolecular weight:511.03Palmatine chloride
CAS:Palmatine chloride an isoquinoline alkaloid, is an important medicinal herbal extract with diverse pharmacological and biological properties.Formula:C21H22ClNO4Purity:97.9% - 99.47%Color and Shape:SolidMolecular weight:387.8573-deazaneplanocin A HCl
CAS:3-deazaneplanocin A HCl is both an S-adenosyl-l-homocysteine hydrolase inhibitor and an enhancer of zeste homolog 2(EZH2) inhibitor.Formula:C12H15ClN4O3Purity:93.24% - 98.34%Color and Shape:SolidMolecular weight:298.73Cenacitinib
CAS:Cenacitinib is an effective inhibitor of Janus kinase (Janus kinase) and possesses anti-inflammatory activity.Formula:C19H19F2N7O3Color and Shape:SolidMolecular weight:431.40SGI-1776
CAS:SGI-1776 (Pim-Kinase Inhibitor IX) has been used in trials studying the treatment of Prostate Cancer, Non-Hodgkins Lymphoma, and Relapsed/Refractory Leukemias.Formula:C20H22F3N5OPurity:100% - 99.84%Color and Shape:SolidMolecular weight:405.42WDR5-0102
CAS:WDR5-0102 inhibits WDR5-MLL1 (Kd=4 μM), blocks MLL1 HMT activity, but doesn't affect SETD7 and 6 other HMTs.Formula:C18H19ClN4O3Purity:97.16%Color and Shape:SolidMolecular weight:374.82Ref: TM-T67947
1mg77.00€5mg169.00€10mg274.00€25mg550.00€50mg792.00€100mg1,093.00€500mg2,175.00€1mL*10mM (DMSO)215.00€Nimucitinib
CAS:Nimucitinib is a Janus kinase (JAK) inhibitor that can be used to treat dry eye and promote tear production.Formula:C25H26F2N6O2Purity:98.71%Color and Shape:SoildMolecular weight:480.51Ref: TM-T67907
1mg96.00€2mg139.00€5mg227.00€10mg354.00€25mg653.00€50mg938.00€100mg1,454.00€500mg2,822.00€HDACs/EZH2-IN-1
HDACs/EZH2-IN-1 (Compound 22a) is a dual inhibitor of HDACs and EZH2, exhibiting potent inhibitory activity, with EZH2 Y641N being suppressed by 98% at 50 nM. It selectively targets HDAC1 and HDAC6, with IC50 values of 0.23 μM and 0.07 μM, respectively. HDACs/EZH2-IN-1 effectively inhibits the proliferation of diffuse large B-cell lymphoma cells harboring EZH2 mutations and various acute myeloid leukemia cells. Additionally, this compound has the capability to induce cellular differentiation and apoptosis (Apoptosis).Formula:C29H36BrN7O4Color and Shape:SolidMolecular weight:626.54Igermetostat
CAS:Igermetostat, an EZH2 inhibitor, is utilized both in vivo and in vitro for cancer research [1].Formula:C32H46N4O4Purity:98%Color and Shape:SolidMolecular weight:550.73G244-LM
CAS:G244-LM is a potent and specific inhibitor of tankyrase 1/2. G244-LM inhibits Wnt signaling.Formula:C18H22N4O3S2Purity:98.46%Color and Shape:SolidMolecular weight:406.52Dihydro-5-azacytidine
CAS:Dihydro-5-azacytidine (DHAC) is a nucleoside analog that interrupts DNA methylation by integrating into DNA. It also exhibits notable antitumor properties.Formula:C8H14N4O5Purity:100%Color and Shape:SolidMolecular weight:246.22PHD-IN-2
CAS:PHD-IN-2 (Compound 91), a potent PHD antagonist with an IC50 of less than 5 nM, effectively stimulates erythropoietin synthesis in HEP3B cells with an EC50 ofFormula:C26H27N7O4Purity:98%Color and Shape:SolidMolecular weight:501.54Cycloastragenol
CAS:Cycloastragenol, a saponin from Astragalus, could be a new depression treatment.Formula:C30H50O5Purity:99.85% - 99.92%Color and Shape:SolidMolecular weight:490.71I-CBP112
CAS:I-CBP112 is a specific and potent acetyl-lysine competitive protein-protein interaction inhibitor targeting the CBP/p300 bromodomains.Formula:C27H36N2O5Purity:98.18%Color and Shape:SolidMolecular weight:468.59Ref: TM-T3969
1mg34.00€2mg52.00€5mg97.00€10mg170.00€25mg313.00€50mg449.00€100mg615.00€200mg830.00€1mL*10mM (DMSO)97.00€JAK-IN-34
CAS:JAK-IN-34 (compound 11n) is a potent inhibitor of Janus kinases (JAKs), demonstrating IC50 values of 0.40 nM for JAK1, 0.83 nM for JAK2, 2.10 nM for JAK3,Formula:C27H26N6OPurity:98%Color and Shape:SolidMolecular weight:450.53PARP10-IN-3
CAS:PARP10-IN-3: selective inhibitor for mono-ADP-ribotransferase PARP10 (IC50: 480nM), also affects PARP2 and PARP15 (IC50: 1.7μM).Formula:C14H12N2O3Purity:99.54%Color and Shape:SoildMolecular weight:256.26Ref: TM-T67932
2mg37.00€5mg52.00€10mg88.00€25mg160.00€50mg250.00€100mg399.00€500mg908.00€1mL*10mM (DMSO)58.00€Tilorone dihydrochloride
CAS:Tilorone dihydrochloride is an orally active interferon inducer, and has antineoplastic and anti-inflammatory actions.Formula:C25H36Cl2N2O3Purity:98% - 99.86%Color and Shape:Orange Yellow Crystal PowderMolecular weight:483.47XMD8-92
CAS:XMD8-92 is an effective and specific BMK1/ERK5 inhibitor (Kd: 80 nM).Formula:C26H30N6O3Purity:98.21%Color and Shape:SolidMolecular weight:474.55SYP-5
CAS:SYP-5 is a novel inhibitor of HIF-1, suppresses tumor cells invasion and angiogenesis.Formula:C18H16O3SPurity:98.31%Color and Shape:SolidMolecular weight:312.38Anti-PARP1 Antibody (6I459)
Anti-PARP1 Antibody (6I459) is an antibody targeting PARP1. Anti-PARP1 Antibody (6I459) can be used in ELISA, IHC.Color and Shape:Odour LiquidSMD-3236
CAS:SMD-3236 is a PRAOTAC degrader targeting SMARCA2, designed using SMARCA ligand and VHL-1 ligand, and exhibits prolonged anti-tumor activity in vivo. SMARCA2 acts as a synthetic lethal target in cancer cells lacking SMARCA4, with SMD-3236 showing 2000-fold selectivity for SMARCA2 over SMARCA4, having a DC50 of less than 1 nM and a Dmax of over 95%. In the human cancer xenograft models deficient in SMARCA4, notably the H838 model, SMD-3236 effectively induces loss of SMARCA2 in tumor tissue while sparing the SMARCA4 protein, thereby inhibiting tumor growth. The compound consists of a target protein ligand (red part) SMI-1074, a PROTAC linker (black part) (trans-4-Ethynylcyclohexyl)methyl methanesulfonate, and an E3 ligase ligand (blue part) SMARCA2 ligand-14, forming the E3LigaseLigand-linker Conjugate 159.Formula:C61H75ClN10O5SColor and Shape:SolidMolecular weight:1095.83PI3K/Akt/CREB activator 1
CAS:PI3K/Akt/CREB activator 1 (AE-18) is an iNOS inhibitor that can be used to study vascular dementia and Parkinson's.Formula:C19H15F4NO3Color and Shape:SolidMolecular weight:381.32IMM-H007
CAS:IMM-H007 is a novel lipid-lowering agent, increasing abca1 protein expressionFormula:C22H23N5O8Purity:97.73%Color and Shape:SolidMolecular weight:485.45Ref: TM-T9010
1mg40.00€5mg96.00€10mg135.00€25mg226.00€50mg320.00€100mg434.00€200mg602.00€1mL*10mM (DMSO)131.00€(S,R)-CFT8634
CAS:(S,R)-CFT8634 is a selective and orally active BRD9 protein degrader with potential for researching BRD9-mediated disorders, such as abnormal cellularFormula:C37H45F3N6O5Purity:98%Color and Shape:SolidMolecular weight:710.79DC-S239
CAS:Ethyl 2-amino-4-methyl-5-thiophene carboxylate is a SETD7 inhibitor (IC50=4.59μM) with anticancer properties.Formula:C15H15N3O5SPurity:99.36%Color and Shape:SolidMolecular weight:349.36Ref: TM-T60002
1mg49.00€5mg104.00€10mg169.00€25mg329.00€50mg533.00€100mg847.00€200mg1,159.00€1mL*10mM (DMSO)115.00€JAK3/BTK-IN-2
CAS:JAK3/ BTk-in-2 is a potent JAK3/BTK inhibitor.Formula:C25H32N8O2Purity:99.64%Color and Shape:SolidMolecular weight:476.57JQKD82 trihydrochloride
JQKD82 trihydrochloride, a cell-permeable and selective inhibitor of KDM5, enhances H3K4me3 levels and is utilized in multiple myeloma research.Formula:C27H43Cl3N4O5Purity:99.19%Color and Shape:SolidMolecular weight:610.01GW779439X
CAS:GW779439X is an inhibitor of CDK.Formula:C22H21F3N8Purity:97.87%Color and Shape:SolidMolecular weight:454.45Ref: TM-T8866
1mg62.00€2mg87.00€5mg119.00€10mg188.00€25mg425.00€50mg625.00€100mg892.00€1mL*10mM (DMSO)131.00€SIRT5 inhibitor 9
CAS:SIRT5 inhibitor 9 (compound 14) is a moderately selective and substrate-competitive SIRT5 inhibitor with IC50=4.07 μM and has potential anticancer effects.Formula:C24H29ClN8O4SPurity:99.93%Color and Shape:SolidMolecular weight:561.06MAT2A-IN-12
CAS:MAT2A Allosteric Inhibitor 2 is a potent, selective inhibitor exhibiting an IC50 of 5 nM and demonstrates nanomolar efficacy (IC50 = 5 μM) in proliferationFormula:C20H17NO3Purity:98%Color and Shape:SolidMolecular weight:319.35PRMT5-IN-1
CAS:PRMT5-IN-1 is a covalent inhibitor of protein arginine methyltransferase 5 (PRMT5)(IC50 of 11 nM for PRMT5/MEP50).Formula:C19H19ClN4O5Purity:98%Color and Shape:SolidMolecular weight:418.83PHD2-IN-1
CAS:PHD2-IN-1, a potent and orally active HIF prolyl hydroxylase 2 (PHD2) inhibitor, exhibits an IC50 of 22.53 nM and is applicable in anemia research [1].Formula:C21H23ClN4O5Purity:98%Color and Shape:SolidMolecular weight:446.88MRK-740
CAS:MRK-740 is a PRDM9 histone methyltransferase inhibitor that inhibits H3K4 methylation.Formula:C25H32N6O3Purity:99.66%Color and Shape:SolidMolecular weight:464.565-AIQ
CAS:5-aminoisoquinolin-1(2H)-one is the inhibitor of calf thymus PARP1.Formula:C9H8N2OPurity:95.00%Color and Shape:SolidMolecular weight:160.17Angiogenesis agent 1
CAS:Compound C-31, a salidroside-based glycoside, activates HIF-1α and may aid in diabetic limb ischemia studies.Formula:C20H24O7Purity:98%Color and Shape:SolidMolecular weight:376.4DNMT1/HDAC-IN-1
DNMT1/HDAC-IN-1 (compound (R)-23a), a potent dual inhibitor targeting both DNMT1 and HDAC, exhibits impressive inhibitory effects specifically on HDAC1 (HDAC1:IC50=0.05 μM), a major HDAC isoform that interacts with DNMT1 across multiple protein complexes involved in the transcriptional silencing of TSGs. This compound has been shown to remodel the tumor immune microenvironment and induce tumor regression, effectively reversing cancer-specific epigenetic abnormalities.Color and Shape:Odour SolidBromodomain inhibitor-12 (edisylate)
CAS:Bromodomain Inhibitor-12 Edisylate (example 303) serves as a bromodomain inhibitor applicable to autoimmune and inflammatory disease research [1].Formula:C30H44N4O11S2Purity:98%Color and Shape:SolidMolecular weight:700.82Barasertib
CAS:AZD1152 is a pro-drug of Barasertib (AZD1152)-hQPA. Which is a highly selective Aurora B inhibitor with IC50 of 0.37 nM in a cell-free assay.Formula:C26H31FN7O6PPurity:99.63%Color and Shape:SolidMolecular weight:587.54WP1066
CAS:WP1066 is a inhibitor of JAK2 (IC50: 2.30 μM) and STAT3 (IC50: 2.43 μM) in HEL cells; shows activity to JAK2, STAT3/5, and ERK1/2, not JAK1 and JAK3.Formula:C17H14BrN3OPurity:98.92% - 99.73%Color and Shape:SolidMolecular weight:356.22LSD1-IN-39
CAS:LSD1-IN-39 (Compound 14) is a reversible inhibitor of LSD1 with an IC50 of 0.18 μM, showing broad-spectrum antiproliferative activity against cancer cells, inhibiting HepG2 cell migration, and suppressing epithelial-mesenchymal transition. Additionally, LSD1-IN-39 exhibits antitumor activity in mouse models.Formula:C25H30N2O7Color and Shape:SolidMolecular weight:470.515SC99
CAS:SC99 inhibits JAK2-STAT3, reducing STAT3 genes, platelet activity, and has anti-myeloma, anti-thrombotic effects.Formula:C15H8Cl2FN3OPurity:99.56%Color and Shape:SolidMolecular weight:336.15Ref: TM-T8719
1mg46.00€5mg93.00€10mg140.00€25mg240.00€50mg363.00€100mg452.00€200mg630.00€1mL*10mM (DMSO)99.00€JAK3 covalent inhibitor-1
CAS:JAK3 Covalent Inhibitor-1 is a compound characterized by its potent and selective inhibition of Janus kinase 3 (JAK3), possessing an IC50 of 11 nM andFormula:C22H17FN6O2SPurity:98%Color and Shape:SolidMolecular weight:448.47PFI-1
CAS:PFI-1 (PF-6405761), a specific BET (bromodomain-containing protein) inhibitor for BRD4, is with the IC50 of 0.22 μM in a cell-free assay.Formula:C16H17N3O4SPurity:97.21% - 98.59%Color and Shape:SolidMolecular weight:347.39SGI-1027
CAS:SGI-1027 (DNA Methyltransferase Inhibitor II) is an effective and selective inhibitor of DNA methyltransferase (DNMT).Formula:C27H23N7OPurity:99.18% - 99.45%Color and Shape:SolidMolecular weight:461.52Ref: TM-T1904
5mg58.00€10mg94.00€25mg163.00€50mg296.00€100mg467.00€500mg1,035.00€1mL*10mM (DMSO)74.00€AKBA
CAS:AKBA (3-O-Acetyl-11-keto-beta-boswellic acid), a natural component from frankincense, is a novel activator of Nrf2.Formula:C32H48O5Purity:97.85% - 99.77%Color and Shape:SolidMolecular weight:512.72Ref: TM-T5S1569
1g1,863.00€1mg43.00€5mg88.00€10mg117.00€25mg187.00€50mg279.00€100mg439.00€500mg1,188.00€1mL*10mM (DMSO)143.00€SW155246
CAS:SW155246 is a potent and selective inhibitor of DNMT1 (DNA methyltransferase 1; IC50 of 1.2 μM).Formula:C16H11ClN2O5SPurity:97.79%Color and Shape:SolidMolecular weight:378.79CBP/p300-IN-5
CAS:P300/CBP-IN-5 is a potent inhibitor of p300/CBP histone acetyltransferase (IC50 of 18.8 nM).Formula:C29H27F5N6O4Purity:98%Color and Shape:SolidMolecular weight:618.55Dual Cathepsin L/JAK-IN-1
CAS:DualCathepsinL/JAK-IN-1 (Compound A8) serves as a dual inhibitor of Cathepsin L (CTSL) and JAK, exhibiting IC50 values of 0.68 μM for CTSL and 337.1 nM, 5.251 nM, 27.29 nM, and 172.6 nM for JAK1/2/3 and TYK2, respectively. This compound effectively prevents the activation of MAPK, NF-κB, and JAK/STAT signaling pathways, leading to significant anti-inflammatory therapeutic effects. DualCathepsinL/JAK-IN-1 is applicable in research on acute lung injury (ALI).Formula:C19H18ClN5Color and Shape:SolidMolecular weight:351.833ZLD1039
CAS:ZLD1039, an oral EZH2 inhibitor, shows strong PRC2 inhibition at low nanomolar IC50s, and halts breast cancer growth and spread.Formula:C36H48N6O3Purity:99.82%Color and Shape:SolidMolecular weight:612.8BMS-911543
CAS:BMS-911543 is a potent and selective inhibitor of JAK2 with IC50 of 1.1 nM, ~350-, 75- and 65-fold selective to JAK1, JAK3 and TYK2, respectively. Phase 1/2.Formula:C23H28N8OPurity:97.69% - 99.98%Color and Shape:SolidMolecular weight:432.52Adaptaquin
CAS:Adaptaquin is an inhibitor of the hypoxia-inducing factor prolyl hydroxylase (HIF-PH) [1] [2].Formula:C21H16ClN3O2Purity:98.35%Color and Shape:SolidMolecular weight:377.82PHD2-IN-4
CAS:PHD2-IN-4 (compound 1) is an inhibitor of PHD2, with an IC50 of 4 nM. It is utilized in research related to chronic kidney disease.Formula:C21H19N5O3Color and Shape:SolidMolecular weight:389.407Picolinamide
CAS:Picolinamide (Picolinoylamide) is found to be a strong inhibitor of poly (ADP-ribose) synthetase of nuclei from rat pancreatic islet cells.Formula:C6H6N2OPurity:99.60%Color and Shape:SolidMolecular weight:122.12IV-275
IV-275 is a dual inhibitor targeting the bromodomains of both BRG1 and BRM.Formula:C19H18F2N2O3Purity:98%Color and Shape:SolidMolecular weight:360.35Antidiabetic agent 7
Antidiabetic agent 7 (Compound 5m) functions as a potent hyperglycemia inhibitor. It effectively stimulates GLUT4 translocation in skeletal muscle cells by activating the AMPK-dependent pathway. Additionally, this compound is capable of reducing blood glucose levels and exhibits favorable pharmacokinetic properties. Antidiabetic agent 7 is suitable for research related to antihyperglycemic treatments.Formula:C27H21Cl2N5O3Color and Shape:SolidMolecular weight:534.39Ziftomenib
CAS:Ziftomenib (KO-539) is an inhibitor of menin-MLL interaction with antitumor activity and can be used to study leukemia.Formula:C33H42F3N9O2S2Purity:99.65%Color and Shape:SolidMolecular weight:717.871TM6089
CAS:TM6089 is an inhibitor of Prolyl Hydroxylase that stimulates HIF activity without iron chelation, induces angiogenesis, and protects organ against ischemia.Formula:C13H14N4O3SPurity:99.07%Color and Shape:SolidMolecular weight:306.34Ref: TM-T17105
1mg74.00€5mg164.00€10mg239.00€25mg430.00€50mg645.00€100mg940.00€200mg1,264.00€1mL*10mM (DMSO)170.00€Oltipraz
CAS:Oltipraz (RP 35972) is a synthetic dithiolethione with potential chemopreventive and anti-angiogenic properties.Formula:C8H6N2S3Purity:100% - 99.56%Color and Shape:SolidMolecular weight:226.34BET bromodomain inhibitor
CAS:BET bromodomain inhibitor is a potent BET inhibitor.Formula:C24H20ClN5O2Purity:98.22% - 99.26%Color and Shape:SolidMolecular weight:445.9PARP1/2-IN-4
CAS:PARP1/2-IN-4 (compound 3) is an inhibitor of PARP1/2.Formula:C23H30FN5O6Color and Shape:SolidMolecular weight:491.515-Fluoro-2'-deoxycytidine
CAS:5-Fluoro-2'-deoxycytidine (2'-DEOXY-5-FLUOROCYTIDINE) is an inhibitor of DNA methyltransferase (DNMT) .Formula:C9H12FN3O4Purity:97.91%Color and Shape:Fine White PowderMolecular weight:245.21Ref: TM-T7718
2mg35.00€5mg50.00€10mg67.00€25mg96.00€50mg145.00€100mg210.00€200mg313.00€500mg525.00€1mL*10mM (DMSO)52.00€GDC-0339
CAS:GDC-0339: oral Pim kinase inhibitor for multiple myeloma (Kis: Pim1 - 0.03 nM, Pim2 - 0.1 nM, Pim3 - 0.02 nM), well-tolerated.Formula:C20H22F3N7OSColor and Shape:SolidMolecular weight:465.5Decernotinib
CAS:Decernotinib (VRT-831509)(VX-509; VRT-831509) is a potent and selective Janus kinase 3 (JAK3) inhibitor with Ki of 2.5 nM; IC50 is 50-170 nM in cellular assays.Formula:C18H19F3N6OPurity:100% - 99.45%Color and Shape:SolidMolecular weight:392.38Ref: TM-T2636
1mg38.00€2mg52.00€5mg79.00€10mg110.00€25mg217.00€50mg329.00€100mg494.00€200mg705.00€1mL*10mM (DMSO)88.00€PROTAC SMARCA2 degrader-28
CAS:PROTAC SMARCA2 degrader-28 (Compound 158) is a potent SMARCA2 PROTAC degrader that achieves degradation of SMARCA2 in HiBiT A549 cells, exhibiting a DC50 of 3 nM.Formula:C50H51F7N10O10Color and Shape:SolidMolecular weight:1084.99CTPB
CAS:CTPB is a potent p300 histone acetyltransferase (HAT) activator that can be used in the preparation of hair growth promoters and/or hair loss treatments.Formula:C31H43ClF3NO2Purity:99.77%Color and Shape:SolidMolecular weight:554.13MRTX-1719
CAS:MRTX-1719 is a potent and selective inhibitor of the PRMT5/MTA complex with an IC50 value of <10 nM against PRMT5/MTAMTAPDELSDMA cell lines.Cost-effective and quality-assured.Formula:C23H18ClFN6O2Purity:98.27% - 99.18%Color and Shape:SolidMolecular weight:464.88Ref: TM-T40254
1mg379.00€5mg740.00€10mg1,005.00€25mg1,679.00€50mg2,355.00€100mg3,437.00€1mL*10mM (DMSO)758.00€FHD-286
CAS:FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.Formula:C24H30N6O6S2Purity:98.7%Color and Shape:SolidMolecular weight:562.66Ref: TM-T9749
1mg145.00€5mg354.00€10mg550.00€25mg747.00€50mg938.00€100mg1,293.00€500mg2,593.00€1mL*10mM (DMSO)378.00€dCBP-1
CAS:dCBP-1 selectively degrades p300/CBP via CRBN, killing multiple myeloma cells.Formula:C51H63F2N11O10Purity:98.21% - 99.12%Color and Shape:SolidMolecular weight:1028.11AMI-408
CAS:AMI-408 is a PRMT1 inhibitor that effectively reduces the levels of H4R3me2as in MLL-GAS7 leukemia cells.Formula:C20H13Cl2N6NaO5SColor and Shape:SolidMolecular weight:543.32MS7972
CAS:MS7972 is CREBBP inhibitor that blocks human p53 and CREB binding protein association. MS7972 can almost completely block this BRD interaction at 50 μMFormula:C14H13NO2Purity:99.78%Color and Shape:SolidMolecular weight:227.26Ref: TM-T8774
1mg57.00€5mg111.00€10mg183.00€25mg311.00€50mg449.00€100mg615.00€200mg830.00€1mL*10mM (DMSO)123.00€Barasertib-HQPA
CAS:Barasertib-HQPA (AZD2811) is a highly selective Aurora B inhibitor (IC50: 0.37 nM) and demonstrates ~3,700-fold greater selectivity than Aurora A.Formula:C26H30FN7O3Purity:98.43% - 99.29%Color and Shape:SolidMolecular weight:507.56AAPK-25
CAS:AAPK-25, a dual Aurora/PLK inhibitor, disrupts mitosis, induces apoptosis, and has antitumor properties.Formula:C21H13Cl2N3O2SPurity:97.79%Color and Shape:SolidMolecular weight:442.32Ref: TM-T10215
1mg95.00€5mg202.00€10mg303.00€25mg550.00€50mg825.00€100mg1,198.00€1mL*10mM (DMSO)233.00€PROTAC BRD4 Degrader-2
CAS:PROTAC BRD4 Degrader-2 is an efficacious degrader of PROTAC BRD4(BRD4 BD1,IC50 of 14.2 nM).Formula:C40H39N9O7Purity:98%Color and Shape:SolidMolecular weight:757.79KDM1A-IN-29
CAS:KDM1A-IN-29 is a histone demethylase inhibitor.Formula:C16H16ClN3O4SColor and Shape:SoildMolecular weight:381.83Larsucosterol Ammonium salt
CAS:Larsucosterol ammonium salt is a derivative of 25HC3S. It is a DNMT inhibitor, a LXR antagonist, an endogenous epigenetic modulator of lipid metabolism.Formula:C27H49NO5SPurity:100% - 100%Color and Shape:SoildMolecular weight:499.75Hispidulin
CAS:Hispidulin, a natural flavone with a broad spectrum of biological activities, is a Pim-1 inhibitor (IC50: 2.71 μM).Formula:C16H12O6Purity:97.54% - 98.53%Color and Shape:SolidMolecular weight:300.26BI-9564
CAS:BI-9564, a specific cell-permeable BRD9 BD inhibitor. The Kd for BRD9 is 5.9 nM, and IC50 for BET family is > 100 μM.Formula:C20H23N3O3Purity:98.77%Color and Shape:SolidMolecular weight:353.41PF-9366
CAS:PF-9366 is a human methionine adenosyltransferase 2A (Mat2A) inhibitor (IC50: 420 nM; Kd: 170 nM).Formula:C20H19ClN4Purity:100% - 98.99%Color and Shape:SolidMolecular weight:350.84HDAC-IN-87
CAS:HDAC-IN-87 (Compound XII6) is a non-selective HDAC inhibitor with pIC50 values of 6.9 for HDAC4 and 5.8 for HDAC6. It exhibits fungicidal activity against P. sorghi and P. pachyrhizi. The acute oral LD50 in both male and female rats is greater than 500 mg/kg.Formula:C13H7F5N4O2SColor and Shape:SolidMolecular weight:378.277Pim1/AKK1-IN-1
CAS:Pim1/AKK1-IN-1: LKB1/AAK1 inhibitor with Kd 35/53/75/380 nM for Pim1/AKK1/MST2/LKB1, also targets MPSK1, TNIK.Formula:C20H13N5OPurity:97.84% - 98.69%Color and Shape:SolidMolecular weight:339.35Ref: TM-T5093
1mg89.00€2mg131.00€5mg183.00€10mg278.00€25mg490.00€50mg710.00€100mg998.00€1mL*10mM (DMSO)202.00€Milpecitinib
CAS:Milpecitinib (Compound 21a) is a potent and selective Janus tyrosine kinase (JAK) inhibitor with anti-inflammatory properties. It shows promise for research in cancer and inflammatory diseases.Formula:C20H20N4O2SColor and Shape:SolidMolecular weight:380.463BRD4-BD1-IN-2
CAS:BRD4-BD1-IN-2: Potent, selective BRD4-BD1 inhibitor, IC50=2.51µM; 20x less active on BD2; for cardiovascular/cancer research.Formula:C20H15Br3N4O2Purity:99.47%Color and Shape:SolidMolecular weight:583.07ZEN-3694
CAS:ZEN-3694 (ZEN 3694) is a bromo-structural domain extra-terminal inhibitor (BETi) with activity in androgen signaling inhibitor (ASI) resistance models and canFormula:C19H19N5OPurity:98.88% - 99.48%Color and Shape:SolidMolecular weight:333.39PF-CBP1
CAS:PF-CBP1 HCl is a highly selective inhibitor of the bromodomain of CREB-binding protein(CREBBP).Formula:C29H36N4O3Purity:99.45%Color and Shape:SolidMolecular weight:488.62Ref: TM-T3973
2mg34.00€5mg46.00€10mg72.00€25mg128.00€50mg224.00€100mg331.00€200mg465.00€1mL*10mM (DMSO)46.00€PLX51107
CAS:PLX51107 is a potent and selective BET inhibitor (Kds: 1.6, 2.1, 1.7, and 5 nM for BRD2-BD1, BRD3-BD1, BRD4-BD1, and BRDT-BD1).Formula:C26H22N4O3Purity:99.75%Color and Shape:SolidMolecular weight:438.48Ref: TM-TQ0253
1mg56.00€2mg81.00€5mg119.00€10mg188.00€25mg329.00€50mg490.00€100mg710.00€1mL*10mM (DMSO)131.00€UNC6934
CAS:UNC6934 is a chemical probe targeting the N-terminal PWWP (PWWP1) domain of NSD2.Formula:C24H21N5O4Purity:99.81%Color and Shape:SolidMolecular weight:443.45Ref: TM-T9584
1mg86.00€2mg111.00€5mg180.00€10mg283.00€25mg455.00€50mg645.00€100mg882.00€500mg1,758.00€1mL*10mM (DMSO)188.00€Aurora kinase inhibitor-3
CAS:Aurora kinase inhibitor-3 (Aurora Kinase Inhibitor III) is a potent inhibitor of Aurora A kinase (IC50 = 42 nM).1 It is selective for Aurora A over BMX, BTK,Formula:C21H18F3N5OPurity:98.91%Color and Shape:SolidMolecular weight:413.4Ref: TM-T5524
1mg78.00€2mg97.00€5mg188.00€10mg298.00€25mg500.00€50mg710.00€100mg938.00€200mg1,311.00€1mL*10mM (DMSO)215.00€EP300/CBP ligand 2
EP300/CBP ligand 2 (compound S19) serves as a specific ligand for the bromodomain of CREB binding protein (CBP) and E1A-associated protein (EP300). It plays a critical role in PROTAC technology by acting as a target protein ligand. By linking to an E3 ubiquitin ligase ligand via the PROTAC Linker, it facilitates the synthesis of PROTAC molecules capable of targeted protein degradation. For instance, when EP300/CBP ligand 2 is connected to the conjugate (E3 ubiquitin enzyme ligand + Linker) Thalidomide-NH-C10-Boc, it results in the formation of the PROTAC molecule dCE-2.Formula:C20H18N6OColor and Shape:SolidMolecular weight:358.4CX-6258
CAS:CX-6258 is an orally valid Pim 1/2/3 kinase(IC50=5 nM/25 nM/16 nM) inhibitor. It has good biological activity and kinase specificity.Formula:C26H24ClN3O3Purity:95.88%Color and Shape:SolidMolecular weight:461.94Ref: TM-T1834
1mg37.00€5mg80.00€10mg106.00€25mg208.00€50mg311.00€100mg472.00€200mg658.00€1mL*10mM (DMSO)81.00€Anti-PARP1 Antibody (7A800)
Anti-PARP1 Antibody (7A800) is an antibody targeting PARP1. Anti-PARP1 Antibody (7A800) can be used in ELISA, WB, IHC.Color and Shape:Odour LiquidI-BET151
CAS:I-BET151 (GSK1210151A) (GSK1210151A) is a specific BET inhibitor for BRD2/3/4 (IC50: 0.5/0.25/0.79 μM, in cell-free assays).Formula:C23H21N5O3Purity:97.34% - 99.63%Color and Shape:SolidMolecular weight:415.44Ref: TM-T2120
1mg48.00€2mg65.00€5mg96.00€10mg115.00€25mg202.00€50mg339.00€100mg507.00€500mg1,130.00€1mL*10mM (DMSO)105.00€Annaosanchun
CAS:Annaosanchun (YC-6) is potentially for the treatment of acute ischemic stroke (AIS).Formula:C19H32O3Purity:99.58%Color and Shape:SolidMolecular weight:308.46INCB-057643
CAS:INCB057643 is a potent, selective and orally bioavailable BET inhibitor.Formula:C20H21N3O5SPurity:99.50%Color and Shape:SolidMolecular weight:415.46Ref: TM-T5417
1mg42.00€5mg90.00€10mg140.00€25mg245.00€50mg368.00€100mg500.00€200mg688.00€1mL*10mM (DMSO)90.00€PBRM1-BD2-IN-5
CAS:PBRM1-BD2-IN-5 is a potent inhibitor of the PBRM1 Bromodomain, demonstrating dissociation constant (Kd) values of 1.5 μM and 3.9 μM for PBRM1-BD2 and PBRM1-BD5Formula:C15H13ClN2OPurity:99.55%Color and Shape:SoildMolecular weight:272.73Ref: TM-T60159
1mg96.00€2mg125.00€5mg188.00€10mg301.00€25mg454.00€50mg605.00€100mg837.00€500mg1,681.00€1mL*10mM (DMSO)180.00€Benzamide
CAS:Benzamide (Amid kyseliny benzoove), an inhibitor of poly(ADP-ribose) polymerase, is a derivative of benzoic acid.Formula:C7H7NOPurity:99.66%Color and Shape:Colorless Crystals Physical Description White Powder (Ntp 1992)Molecular weight:121.14Antiproliferative agent-25
Antiproliferative Agent-25 (Compound 3s4) is a selective PRMT5 inhibitor displaying an IC50 of 0.11 μM.Formula:C20H21BrN2O2Purity:98%Color and Shape:SolidMolecular weight:401.3BRD7-IN-2
BRD7-IN-2 (compound 2-77) is a potent selective inhibitor of bromodomain-containing protein 7 (BRD7), exhibiting significant anti-proliferative activity inFormula:C18H18N2O3Purity:98%Color and Shape:SolidMolecular weight:310.35Dot1L-IN-8
Dot1L-IN-8 (Compound 15) is an effective Dot1L inhibitor. It suppresses the viability of HL-60, K562, MV4-11, HH, and KG-1 cells, with IC50 values of 0.45, 1.03, 0.68, 1.66, and 1.12 μM, respectively.Formula:C41H53N7O3SColor and Shape:SolidMolecular weight:723.97RN-1 dihydrochloride
CAS:RN-1 dihydrochloride is an effective and selective irreversible inhibitor of lysine-specific demethylase 1 (LSD1, IC50 = 70 nM).Formula:C23H31Cl2N3O2Purity:99.61%Color and Shape:SolidMolecular weight:452.42MI-538
CAS:MI-538 is an interaction between menin and MLL fusion proteins inhibitor(IC50 of 21 nM).Formula:C27H25F3N8OSPurity:100% - 99.31%Color and Shape:SolidMolecular weight:566.6Ref: TM-T16072
1mg64.00€5mg116.00€10mg188.00€25mg356.00€50mg535.00€100mg730.00€1mL*10mM (DMSO)145.00€MS049
CAS:MS 049 is a potent, selective, and cell-active dual inhibitor of PRMT4 and PRMT6 with IC 50 of 34 nM and 43 nM, respectively.Formula:C15H24N2OPurity:≥95%Color and Shape:SolidMolecular weight:248.36Ref: TM-T4378
2mg35.00€5mg51.00€10mg85.00€25mg158.00€50mg235.00€100mg354.00€200mg520.00€1mL*10mM (DMSO)55.00€SIRT5 inhibitor 8
CAS:SIRT5 inhibitor 8 (compound 10) is a moderately selective and substrate-competitive SIRT5 inhibitor with IC50=5.38 μM, with potential anticancer effects.Formula:C22H25ClN8O2SPurity:99.68%Color and Shape:SolidMolecular weight:501Ilginatinib
CAS:Ilginatinib (NS-018) is a highly active and orally bioavailable inhibitor of JAK2.Formula:C21H20FN7Purity:98.40% - 99.01%Color and Shape:SolidMolecular weight:389.43Ref: TM-T12266
1mg64.00€5mg138.00€10mg187.00€25mg273.00€50mg393.00€100mg562.00€200mg743.00€1mL*10mM (DMSO)133.00€MS417
CAS:MS417 (GTPL7512) is an inhibitor of BET-specific BRD4(BRD4-BD1 and BRD4-BD2 with IC50s of 30, 46 nM and Kds of 36.1, 25.4 nM, respectively), with weakFormula:C20H19ClN4O2SPurity:99.87%Color and Shape:SolidMolecular weight:414.91SR-0813
CAS:SR-0813 is a potent and selective inhibitor of the YEATS domain in ENL/AF9.Formula:C25H32N6O3SPurity:99.72%Color and Shape:SolidMolecular weight:496.62Ref: TM-T40229
1mg42.00€5mg90.00€10mg131.00€25mg266.00€50mg405.00€100mg562.00€200mg743.00€1mL*10mM (DMSO)89.00€MC3343
CAS:MC3343, a DNMT1/3A inhibitor, affects tumor proliferation by blocking osteosarcoma cells in the G1 or G2/M phase and induces osteogenic differentiation.Formula:C27H23N7OPurity:99.73%Color and Shape:SolidMolecular weight:461.52Ref: TM-T203345
1mg185.00€5mg459.00€10mg657.00€25mg1,026.00€50mg1,415.00€100mg1,872.00€200mg2,555.00€DS79932728
CAS:DS79932728 is an orally active inhibitor of G9a and GLP, with IC50 values of 12.6 nM and 75.7 nM, respectively. It induces the production of γ-globin, thereby increasing fetal hemoglobin (HbF) levels. In cynomolgus monkey models, DS79932728 enhances the proportion of F-reticulocytes (F-rets) and shows good oral absorption characteristics.Formula:C19H25N3OColor and Shape:SolidMolecular weight:311.421BRM/BRG1 ATP Inhibitor-1
CAS:BRM/BRG1 ATP Inhibitor-1 is an allosteric dual Brahma homolog (BRM)/SWI/SNF related matrix-associated actin-dependent regulator of chromatin subfamily A memberFormula:C11H9F3N4O2SPurity:98.17% - 99.84%Color and Shape:SolidMolecular weight:318.27Ref: TM-T10616
1mg396.00€5mg612.00€10mg905.00€25mg1,320.00€50mg1,786.00€100mg2,442.00€1mL*10mM (DMSO)465.00€
